Clinical Trials Browser

Unknown × NETWORK × Interventional × Clear all

NCT06327139 2024-03-25

OPEN

Phase 3 Unknown

Head and Neck Neoplasms

NCT00382070 2024-03-22

Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

Phase 3 Unknown

3,966 enrolled 12 charts

Breast Neoplasms

NCT05066607 2024-03-06

IsAMYP

Phase 2 Unknown

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT04253145 2023-11-18

Study to Assess Safety,Tolerability,Efficacy of PM01183 and Atezolizumab in Patients w/ Advanced Small Cell Lung Cancer.

Phase 1/2 Unknown

Small Cell Lung Carcinoma

NCT03088059 2023-11-03

UPSTREAM

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck

NCT05862051 2023-10-17

RESOLUTE

Phase NA Unknown

Gastrointestinal

Colorectal Neoplasms

NCT01082224 2023-07-07

ACRIN6690

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT02365441 2023-07-07

ALT GIST

Phase 2 Unknown

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT02560298 2023-06-22

InterAACT

Phase 2 Unknown

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

NCT03827070 2023-04-25

DPTA

Phase 1 Unknown

Carcinoma, Non-Small-Cell Lung

NCT00951535 2023-04-06

A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17

Phase 2 Unknown

Prostatic Neoplasms

NCT00492778 2023-03-29

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer

Phase 2 Unknown

165 enrolled 15 charts

Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation

NCT03412643 2023-03-06

FB-12

Phase 2 Unknown

Breast Neoplasms

NCT03134118 2023-02-21

NIVOTHYM

Phase 2 Unknown

Thymoma

NCT02172872 2023-02-15

"InDACtion" vs "3+7" Induction in AML

Phase 3 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05660993 2022-12-21

Multicenter Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab, Bendamustine, Gemcitabine, Vinorelbine (Nivo-BeGEV) in Patients With Relapsed/Refractory Hodgkin Lymphoma

Phase 2 Unknown

Hodgkin Disease

NCT05042466 2022-11-16

NWTTPS

Phase 1 Unknown

Depression, Neoplasms, Stress Disorders, Post-Traumatic, Wounds and Injuries, Trauma, Nervous System

NCT02436733 2022-11-07

Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT03373656 2022-07-26

Vaccination for Children of H&O and Their Parents

Phase NA Unknown

Other hematologic neoplasm

Immunologic Deficiency Syndromes, Hematologic Neoplasms

NCT03626922 2022-06-10

Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients

Phase 1 Unknown

Gastrointestinal

Colorectal Neoplasms

NCT03944447 2022-06-02

OMNI-Can

Phase 2 Unknown

200,000 enrolled

Classical hematology

Chronic Traumatic Encephalopathy, Brain Injuries, Traumatic, COVID-19, Acquired Immunodeficiency Syndrome, Amyotrophic Lateral Sclerosis, Anemia, Sickle Cell, Anxiety Disorders, Autistic Disorder, Bipolar Disorder, Colitis, Ulcerative, Crohn Disease, Depression, Epilepsy, Fibromyalgia, Tourette Syndrome, Glaucoma, Hepatitis C, Sleep Initiation and Maintenance Disorders, Multiple Sclerosis, Opioid-Related Disorders, Neoplasms, Parkinson Disease, Seizures, Stress Disorders, Post-Traumatic, Inflammatory Bowel Diseases, Coronavirus Infections, Severe Acute Respiratory Syndrome, Chronic Pain

NCT01880359 2022-05-10

AF CRT +/- Nimorazole in HNSCC

Phase 3 Unknown

Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers

NCT05339204 2022-04-21

The Role of Allo-HSCT in MRD-negative Patients With AML Under the Age of 60 Years in the First Complete Remission

Phase NA Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01547741 2022-04-14

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

Phase 3 Unknown

Breast Neoplasms

NCT02013336 2022-03-31

Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors

Phase 1 Unknown

Neuroblastoma, Recurrence, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma

NCT03457896 2022-03-31

Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms

NCT05191225 2022-03-31

Ultrafast Truxima Infusion in Non-Hodgkin's Lymphoma: Txagorapid Study

Phase 4 Unknown

Lymphoma, Non-Hodgkin

NCT05289336 2022-03-21

DAHANCA 27

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck

NCT01042522 2022-01-25

Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors

Phase 2 Unknown

63 enrolled 16 charts

Granulosa cell tumor of the ovary, Ovarian gynandroblastoma, Sertoli-Leydig Cell Tumor

NCT02773524 2022-01-13

INTEGRATEIIa

Phase 3 Unknown

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

NCT02279771 2022-01-11

LessStoReS

Phase NA Unknown

Gastrointestinal

Rectal Neoplasms, Anastomotic Leak

NCT05158608 2022-01-11

CY25

Phase 3 Unknown

Other hematologic neoplasm

Graft vs Host Disease, Hematologic Neoplasms

NCT01595061 2021-12-29

Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva

Phase 2 Unknown

57 enrolled 11 charts

Vulvar Neoplasms

NCT05148728 2021-12-08

Active Surveillance vs in Office Fulguration for Low Grade Bladder Cancer Tumors

Phase NA Unknown

Urinary Bladder Neoplasms

NCT05123404 2021-11-17

Validation of VI-RADS for the Detection of Detrusor Muscle Invasion

Phase NA Unknown

Urinary Bladder Neoplasms

NCT04089150 2021-10-22

MASTERPLAN

Phase 2 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT00942357 2021-10-19

Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer

Phase 3 Unknown

813 enrolled 14 charts

Endometrial Clear Cell Adenocarcinoma

NCT01562223 2021-10-18

A6701QIBA

Phase NA Unknown

Prostatic Neoplasms

NCT03505944 2021-10-13

VALERIA

Phase 1/2 Unknown

Lymphoma, Non-Hodgkin

NCT00108745 2021-09-30

Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer

Phase 3 Unknown

1,157 enrolled 15 charts

Brenner Tumor, Fallopian Tube Neoplasms

NCT00954174 2021-09-30

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

Phase 3 Unknown

637 enrolled 18 charts

GynecologicSarcoma

Carcinosarcoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02065687 2021-09-30

Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer

Phase 2/3 Unknown

469 enrolled 16 charts

Endometrial Adenocarcinoma

NCT05040867 2021-09-10

Exercise Prescription Guided by Heart Rate Variability in Breast Cancer Patients

Phase NA Unknown

Breast Neoplasms, Motor Activity, Cardiotoxicity

NCT02661152 2021-04-13

DAHANCA30

Phase 3 Unknown

Squamous Cell Carcinoma of Head and Neck, Hypoxia

NCT00653848 2021-03-25

AdRad

Phase 3 Unknown

Prostatic Neoplasms

NCT00433433 2021-02-03

H10

Phase 3 Unknown

Hodgkin Disease, Lymphoma

NCT00626730 2021-02-03

Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Meningioma

Phase 2 Unknown

Meningioma, Central Nervous System Neoplasms

NCT04607694 2020-10-29

DAHANCA 35

Phase NA Unknown

Head and Neck Neoplasms

NCT00983697 2020-10-23

ACRIN6685

Phase NA Unknown

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

NCT02976051 2020-10-20

DAHANCA 33: Image Guided Dose-escalated Radiotherapy to Patients With Hypoxic HNSCC

Phase 2 Unknown

Head and Neck Neoplasms